{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2020", "item": "https://www.patentleaderboard.com/2020/"}, {"@type": "ListItem", "position": 3, "name": "Array Biopharma", "item": "https://www.patentleaderboard.com/2020/company/array-biopharma"}, {"@type": "ListItem", "position": 4, "name": "Martha E. Rodriguez", "item": "https://www.patentleaderboard.com/2020/inventor/fl:ma_ln:rodriguez-10"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
MR

Martha E. Rodriguez — 3 Patents in 2020

ABArray Biopharma: 3 patents #8 of 109Top 8%
MTMirati Therapeutics: 2 patents #2 of 26Top 8%
Boulder, CO: #92 of 709 inventorsTop 15%
Colorado: #519 of 5,433 inventorsTop 10%
Overall (2020): #78,323 of 565,922Top 15%
3 Patents 2020

Issued Patents 2020

Showing 1–3 of 3 patents

Patent #TitleCo-InventorsDate
10689377 KRas G12C inhibitors James F. Blake, Laurence E. Burgess, Mark Joseph Chicarelli, James Gail Christensen, Adam Cook +7 more 2020-06-23
10669269 Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors Mark Laurence Boys, Robert Kirk DeLisle, Erik James Hicken, April L. Kennedy, David A. Mareska +7 more 2020-06-02
10633381 KRas G12C inhibitors James F. Blake, Laurence E. Burgess, Mark Joseph Chicarelli, James Gail Christensen, Jay Bradford Fell +11 more 2020-04-28